Construction
- 1350.365
- -0.768-0.06%
Maybank Securities Adjusts Dyna-Mac Holdings' Price Target to SG$0.52 From SG$0.46, Keeps at Buy
SAC Capital Starts Soilbuild Construction at Buy With SG$0.04 Price Target
OCBC Investment Research Adjusts Dyna-Mac's Price Target to SG$0.445 From SG$0.42, Keeps at Buy
CGS-CIMB Research Adjusts Raffles Medical Group's Price Target to SG$1.16 From SG$1.20, Keeps at Buy
Analysts Offer Insights on Healthcare Companies: Raffles Medical Group (OtherRAFLF), Agilent (A) and Karuna Therapeutics (KRTX)
Maybank Securities Adjusts Dyna-Mac's Price Target to SG$0.38 From SG$0.51, Keeps at Buy
Maybank Securities Downgrades Raffles Medical Group to Hold From Buy, Adjusts Price Target to SG$1.30 From SG$1.65
Hold Rating on Raffles Medical Group Amid Declining Profits and Rising Operational Costs
Nomura Adjusts Raffles Medical's Price Target to SG$1.40 From SG$1.60, Keeps at Buy
Raffles Medical Group's Strategic Expansion and Growth Potential: A Buy Recommendation
UOB Kay Hian Keeps Their Buy Rating on Raffles Medical Group (RAFLF)
Maybank Adjusts Civmec's Price Target to SG$1.05 From SG$1, Keeps at Buy
Maybank Securities Adjusts Dyna-Mac's Price Target to SG$0.51 From SG$0.40, Keeps at Buy
Phillip Securities Remains a Buy on Raffles Medical Group (RAFLF)
Raffles Medical Group (RAFLF) Receives a Buy From UOB Kay Hian
CGS-CIMB Downgrades ISDN Holdings to Reduce From Add, Adjusts Price Target to SG$0.37 From SG$0.61
OCBC Investment Research Adjusts Dyna-Mac Holdings' Price Target to SG$0.415 From SG$0.37, Keeps at Buy
Analysts Are Bullish on These Healthcare Stocks: Raffles Medical Group (RAFLF), Evolent Health (EVH)
Raffles Medical Group (RAFLF) Gets a Buy From RHB Capital
UOB Kay Hian Adjusts Civmec's Price Target to SG$1.23 From SG$1.10, Keeps at Buy